Idelalisib Active Not Recruiting Phase 2 Trials for Small Lymphocytic Lymphoma (SLL) / Leukemia, Lymphocytic, Chronic, B-Cell / Chronic Lymphocytic Leukaemia (CLL) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02639910Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS)
NCT02968563Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
NCT02135133A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL